DMD Systems Recovery, LLC (DMD) proudly announces its recognition on the 2025 MO 100 Top Impact CEO Ranking for the third consecutive year, reinforcing its commitment to sustainable and responsible ...

The trial was able to elicit more than double the microdystrophin gene in patients after 90 days of treatment.

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

Solid Biosciences’ gene therapy uses a shortened version of the dystrophin protein, which is engineered to mimic the key ...

Medically reviewed by Smita Patel, DO Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed ...

Solid Biosciences has surged back into the Duchenne muscular dystrophy (DMD) gene therapy race. | Solid Biosciences has ...

DMD Advocates advised Innov8 Workspaces India Limited on a secondary sale and primary investment by InCred Wealth and ...

Md Mostafizur Rahman has recently been appointed as a deputy managing director (DMD) of Citizens Bank PLC. Prior to joining ...

The Swiss biopharma company said the deal with the German National Association of Statutory Health Insurance Funds (GKV-SV) ...

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...